advertisement
Abstract #10142 Published in IGR 6-1
Canadian study of travatan as replacement therapy (CSTART): switching to travatan can improve long-term care
Klein TClinical and Refractive Optometry 2004; 15: 16-21
Glaucoma affects more than 300,000 Canadians and about 67 million people worldwide. The incidence of this disease is growing by 10% yearly. It is the second leading cause of blindness in the world, and the leading cause of blindness among black people. It causes permanent vision loss due to death of retinal ganglion cells and their axons. Treatment is aimed at slowing down disease progression.
Dr. T. Klein, Osler Eyecare, 210-164 Queen Street East, Brampton, Ontario L6V 1B4, Canada
Classification:
11.4 Prostaglandins (Part of: 11 Medical treatment)
